Key result
Familial genetic background significantly influenced in vitro muscle contractures to halothane and caffeine, with some families showing markedly higher contracture strengths than others.
Observational (n=47)
In vitro muscle contracture tests show significant variability among different families with malignant hyperthermia, providing evidence for genetic influences on the test procedure.
Answers are grounded in this paper and cite their sources.
Familial IVCT variability may affect MH diagnostic thresholds; leaves open genotype-specific reference standardization.
BACKGROUND: The spectrum of the clinical presentation of malignant hyperthermia (MH) and the results of recent linkage studies suggest that there is a degree of heterogeneity in MH susceptibility. In the current study, we analyzed in vitro muscle contracture tests from members of large families with MH to evaluate if the results of these tests could be related to genetic influences. METHODS: Forty-seven subjects from four families with an MH-related death and with at least five clinically MH-susceptible individuals per family, as diagnosed by an in vitro muscle contracture test according to the protocol of the European MH Group, were included in the current analysis. We compared the strength of muscle contractures to challenges of halothane, caffeine, or both and the effect of these two drugs on twitch potentiation in response to supramaximal electrical stimulation among the families. RESULTS: Clinical MH susceptibility was confirmed in 36 individuals, and 11 individuals were diagnosed as MH-negative. In MH-susceptible individuals, muscle contractures to the 2% halothane challenge were significantly higher in family 1 (n = 15; 16.2 +/- 2.9 mN, mean +/- standard error of the mean) and in family 4 (n = 5; 16.4 +/- 5 mN) than in family 2 (n = 9; 5.8 +/- 1.5 mN) or family 3 (n = 7; 6.0 +/- 1.1 mN). Muscle contractures to the caffeine challenge (2 mM) were significantly increased in family 1 (7.3 +/- 1.4 mN) compared with those in family 3 (1.3 +/- 1.0 mN). In addition, we found a dose-dependent twitch potentiation to the halothane challenge in family 2 (P < 0.01) and to the caffeine challenge in families 2 (P < 0.001) and 3 (P < 0.01), whereas there was no twitch potentiation in families 1 and 4. CONCLUSIONS: The differences of in vitro muscle contracture tests among several families with MH provide evidence for genetic influences on the variability of this test procedure. However, it is not known if the observed differences are caused by heterogeneity of the MH gene mutation(s) or by other genetic factors that might modify muscle contractures in vitro.
No takes yet. Share an insight, caveat, or question.
Urwyler et al. (1994) conducted an observational in Malignant hyperthermia (n=47). Familial genetic background vs. Other families was evaluated on Strength of muscle contractures to halothane and caffeine challenges. Familial genetic background significantly influenced in vitro muscle contractures to halothane and caffeine, with some families showing markedly higher contracture strengths than others.
Synapse has enriched 10 related papers. Consider them for comparative context: